最終更新日：2024/08/02
Tivozanib is a promising oral VEGF receptor tyrosine kinase inhibitor.
正解を見る
Tivozanib is a promising oral VEGF receptor tyrosine kinase inhibitor.
編集履歴（0）
Tivozanib is a promising oral VEGF receptor tyrosine kinase inhibitor.
Tivozanib is a promising oral VEGF receptor tyrosine kinase inhibitor.
DiQt（ディクト）
無料
★★★★★★★★★★
